ARCHIVES

John Durant Is Chosen “Cancer Fighter of the Year”.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

Cancer Meetings Listed

November 1, 1996

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994